Page 12 - Scientific Task Force News Today : Breaking News, Live Updates & Top Stories | Vimarsana

  “After 48 days of vaccination so far, my physical condition is 100 percent fit. My body has not observed any change,” said Mr. Hussain, 54, who is a test subject amongst total of 18000 trial participants who received shots of CanSino during Pakistan’s first-ever massive Phase-III (Last Stage) Clinical Trials.   The Clinical Trials was conducted at solely public sector institution, the University of Health Sciences (UHS) officially approved by the government of Pakistan under strict guidelines of the World Health Organization (WHO).   “There was a bit sporadic feeling of nausea an...

Chinese foreign ministry spokesperson says Beijing has decided to provide batch of vaccine doses to Pakistan "as aid".

The only hurdle in importing the Covid-19 vaccine from Chinese state-owned company Sinopharm will be removed soon with its Phase-I trial in Karachi reaching the final stage. — Reuters/File ISLAMABAD: As the novel coronavirus continues to claim dozens of lives a day in Pakistan, the only hurdle in importing the Covid-19 vaccine from Chinese state-owned company Sinopharm will be removed soon with its Phase-I trial in Karachi reaching the final stage, it emerged on Tuesday. In a separate development, the federal government has decided to implement the Medical Teaching Institutions (MTI) Ordina...

Infections in the country cross 497,210 with 2,435 new cases in last 24 hours

Pakistan is expecting to complete the clinical trial of a Covid-19 vaccine in the current week. — AFP/File ISLAMABAD: As over 17,000 out of 18,000 volunteers have been vaccinated, Pakistan is expecting to complete the clinical trial of a Covid-19 vaccine in the current week. While critics said the country should have pre-booked the vaccine, some experts are of the opinion that by the end of the first quarter of the year, tens of options will be available for the procurement of vaccine. In August last year, the Drug Regulatory Authority of Pakistan (Drap) gave a nod to hold the clinical tria...